Evidence map›Paper›PMID 28049451›Full record

ArticleBMC infectious diseases2017

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure.

Serge C Billong, Jacob Dee, Joseph Fokam, Georges Nguefack-Tsague, Gabriel L Ekali, Raoul Fodjo, Edith S Temgoua, Edson-Joan Billong, Samuel M Sosso, Jembia J Mosoko and 5 more

Abstract readEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Serge C BillongNational HIV drug resistance surveillance and prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon. sergebillong@yahoo.fr.
Jacob DeeCenters for Disease Control and Prevention, Division of Global HIV/AIDS, Atlanta, USA.
Joseph FokamNational HIV drug resistance surveillance and prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon. josephfokam@gmail.com.
Georges Nguefack-TsagueNational HIV drug resistance surveillance and prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon.
Gabriel L EkaliCentral Technical Group, National AIDS Control Committee, Ministry of Public Health, Yaoundé, Cameroon.
Raoul FodjoCentral Technical Group, National AIDS Control Committee, Ministry of Public Health, Yaoundé, Cameroon.
Edith S TemgouaChantal BIYA International Reference Centre (CIRCB) for research on HIV/AIDS prevention andmanagement, Yaoundé, Cameroon.
Edson-Joan BillongFaculty of Medicine, University of Antanarivo, Antananarivo, Madagascar.
Samuel M SossoChantal BIYA International Reference Centre (CIRCB) for research on HIV/AIDS prevention andmanagement, Yaoundé, Cameroon.
Jembia J MosokoCenters for Disease Control and Prevention, Division of Global HIV/AIDS, Cameroon Country Office, Yaoundé, Cameroon.
Francisca MonebenimpFaculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé1, Yaoundé, Cameroon.
Alexis NdjoloFaculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé1, Yaoundé, Cameroon.
Anne-Cecile Z-K BissekNational HIV drug resistance surveillance and prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon.
Omotayo BoluCenters for Disease Control and Prevention, Division of Global HIV/AIDS, Cameroon Country Office, Yaoundé, Cameroon.
Jean-Bosco N ElatNational HIV drug resistance surveillance and prevention Working Group (HIVDR-WG), National AIDS Control Committee, Yaoundé, Cameroon.

Funding

PREVENTION OF HIV INFECTION IN HEALTH CARE SETTINGS IN CAMEROONU2GPS002758 · PS · NATIONAL AIDS CONTROL COMMITTEE · PI ELAT, JEAN BOSCO NFETAM · 2010 to 2015
$11.3M
NCHHSTP CDC HHS U2G PS002758
6 · The paper itself

Abstract

backgroundIn low-income countries (LICs), HIV sentinel surveillance surveys (HIV-SSS) are recommended in between two demographic and health surveys, due to low-cost than the latter. Using the classical unlinked anonymous testing (UAT), HIV-SSS among pregnant women raised certain ethical and financial challenges. We therefore aimed at evaluating how to use prevention of mother-to-child transmission of HIV (PMTCT) routine data as an alternative approach for HIV-SSS in LICs.

methodsA survey conducted through 2012 among first antenatal-care attendees (ANC1) in the ten regions of Cameroon. HIV testing was performed at PMTCT clinics as-per the national serial algorithm (rapid test), and PMTCT site laboratory (PMTCT-SL) performances were evaluated by comparison with results of the national reference laboratory (NRL), determined as the reference standard.

resultsAcceptance rate for HIV testing was 99%, for a total of 6521 ANC1 (49 · 3% aged 15-24) enrolled nationwide. Among 6103 eligible ANC1, sensitivity (using NRL testing as the reference standard) was 81 · 2%, ranging from 58 · 8% (South region) to 100% (West region); thus implying that 18 · 8% HIV-infected ANC1 declared HIV-negative at the PMTCT-SL were positive from NRL-results. Specificity was 99 · 3%, without significant disparity across sites. At population-level, this implies that every year in Cameroon, ~2,500 HIV-infected women are wrongly declared seronegative, while ~1,000 are wrongly declared seropositive. Only 44 · 4% (16/36) of evaluated laboratories reached the quality target of 80%.

conclusionsThe study identified weaknesses in routine PMTCT HIV testing. As Cameroon transitions to using routine PMTCT data for HIV-SSS among pregnant women, there is need in optimizing quality system to ensure robust routine HIV testing for programmatic and surveillance purposes.

Indexed as

Sentinel SurveillanceAdolescentAdultCameroonDatabases, FactualFeasibility StudiesFemaleHIV-1HIV InfectionsHumansInfectious Disease Transmission, VerticalMass ScreeningMiddle AgedPovertyPregnancyPregnancy Complications, Infectious

Identifiers

PMID28049451
PMCPMC5209823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.